THE EFFECT OF BIOLOGIC AND TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS ON WORK PARTICIPATION IN LONGSTANDING RHEUMATOID ARTHRITIS: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW

被引：1
|
作者：
Alunno, A. [1 ]
Marques, M. L. [2 ,3 ]
Falzon, L. [4 ]
Ramiro, S. [2 ,5 ]
Boonen, A. [6 ]
机构：
[1] Univ LAquila, Dept Life Hlth & Environm Sci, Internal Med & Nephrol Unit, Laquila, Italy
[2] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands
[3] Coimbra Univ Hosp, Dept Rheumatol, Coimbra, Portugal
[4] Univ Sheffield, Sch Hlth & Related Res, Hlth Econ & Decis Sci, Sheffield, S Yorkshire, England
[5] Zuyderland Med Ctr, Dept Rheumatol, Herleen, Netherlands
[6] Maastricht Univ, Dept Rheumatol, Med Ctr, Maastricht, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.3562
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0364
引用
收藏
页码：1309 / 1309
页数：1
相关论文
共 50 条
  • [31] Combination Therapy with Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis
    Toby Garrood
    David L. Scott
    BioDrugs, 2001, 15 : 543 - 561
  • [32] RHEUMATOID ARTHRITIS PATIENT CLUSTERS WITH FIRST-TIME BIOLOGIC OR TARGETED SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IDENTIFIED THROUGH DEEP LEARNING
    Kalweit, M.
    Burden, A. M.
    Hugle, T.
    Burkard, T.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S335 - S335
  • [33] Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?
    Scott, I. C.
    Kingsley, G. H.
    Scott, D. L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : S4 - S8
  • [34] 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis
    Louthrenoo, Worawit
    Kasitanon, Nuntana
    Katchamart, Wanruchada
    Aiewruengsurat, Duangkamol
    Chevaisrakul, Parawee
    Chiowchanwisawakit, Praveena
    Dechanuwong, Pornchai
    Hanvivadhanakul, Punchong
    Mahakkanukrauh, Ajanee
    Manavathongchai, Siriporn
    Muangchan, Chayawee
    Narongroeknawin, Pongthorn
    Phumethum, Veerapong
    Siripaitoon, Boonjing
    Suesuwan, Anawat
    Suwannaroj, Siraphop
    Uea-Areewongsa, Parichat
    Ukritchon, Sittichai
    Asavatanabodee, Paijit
    Koolvisoot, Ajchara
    Nanagara, Ratanavadee
    Totemchokchyakarn, Kitti
    Nuntirooj, Kanokrut
    Kitumnuaypong, Tasanee
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (09) : 1166 - 1184
  • [35] Predictors at Diagnosis for Start of Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis
    Hameed, M.
    Exarchou, S.
    Eberhard, A.
    Sharma, A.
    Bergstrom, U.
    Einarsson, J.
    Turesson, C.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 67 - 68
  • [36] Predictors at Diagnosis for Start of Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis
    Hameed, Mohaned
    Exarchou, Sofia
    Eberhard, Anna
    Sharma, Ankita
    Bergstrom, Ulf
    Einarsson, Jon
    Turesson, Carl
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2831 - 2833
  • [37] Decreased chronic kidney disease in rheumatoid arthritis in the era of biologic disease-modifying anti-rheumatic drugs
    Hanaoka, Hironari
    Kikuchi, Jun
    Hiramoto, Kazuoto
    Saito, Shuntaro
    Kondo, Yasushi
    Kaneko, Yuko
    CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1373 - 1378
  • [38] Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers
    Shimada, Hiromi
    Kameda, Tomohiro
    Kanenishi, Kenji
    Miyatake, Nobuyuki
    Nakashima, Shusaku
    Wakiya, Risa
    Kato, Mikiya
    Miyagi, Taichi
    Mansour, Mai Mahmoud Fahmy
    Hata, Toshiyuki
    Kadowaki, Norimitsu
    Dobashi, Hiroaki
    CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1453 - 1458
  • [39] Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers
    Hiromi Shimada
    Tomohiro Kameda
    Kenji Kanenishi
    Nobuyuki Miyatake
    Shusaku Nakashima
    Risa Wakiya
    Mikiya Kato
    Taichi Miyagi
    Mai Mahmoud Fahmy Mansour
    Toshiyuki Hata
    Norimitsu Kadowaki
    Hiroaki Dobashi
    Clinical Rheumatology, 2019, 38 : 1453 - 1458
  • [40] GLUCOCORTICOID SPARING EFFECT OF THE BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS IN TUNISIAN REAL LIFE PRACTICE
    Fakhfakh, R.
    Zeglaoui, H.
    El Amri, N.
    Hamila, S.
    Amara, N.
    Baccouche, K.
    Bouajina, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1439 - 1439
12345